|
|
|
|
|
by randcraw
1961 days ago
|
|
If they target the first type, won't there be TWO competitors where there used to be a monopoly? Shouldn't prices then come down? As to the second type, just because there's an oligopoly doesn't mean competition will ensue and prices must drop. Look at the insane price on insulins. I suspect their intended mission is to cover their costs with only a modest profit and thereby drive down prices where they are most inflated. Given the proliferation of people like Martin Shkreli and companies like Purdue, there's a lot of pharmaceutical fruit out there to be pulled down and made low hanging once more. |
|